DBCO-PEG-NHS (MW 2000)
DBCO-PEG-NHS (MW 2000) is a PEG derivative consisting of DBCO, PEG units, and NHS ester. NHS ester can bind to amino acids or other molecules containing amino groups. DBCO-PEG-NHS (MW 2000) contains a DBCO group and can undergo a strain-promoted alkyne-azide cycloaddition reaction (SPAAC) with molecules containing an azide group[1].
Product Specifications
UNSPSC
12352200
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Smiles
O=C(N1C2=CC=CC=C2C#CC3=CC=CC=C3C1)CCCCC(NCCOCCOCC(ON4C(CCC4=O)=O)=O)=O.[n]
Molecular Weight
2000 (Average)
References & Citations
[1]Hood ED, et al. Vascular Targeting of Radiolabeled Liposomes with Bio-Orthogonally Conjugated Ligands: Single Chain Fragments Provide Higher Specificity than Antibodies. Bioconjug Chem. 2018 Nov 21;29 (11) :3626-3637.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040009-100 1x 100 µL
MART-1 / Melan-A (M2-7C10), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040669-500 1x 500 µL
P27 / KIP1 (SX53G8), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742946-500 1x 500 µL
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details